Features | Partner Sites | Information | LinkXpress
Sign In
Advantech Europe

Expandable Arterial Stent Helps Treat Iliac Stenosis

By HospiMedica International staff writers
Posted on 03 Jun 2014
Image: The Visi-Pro balloon-expandable stent system (Photo courtesy of Covidien).
Image: The Visi-Pro balloon-expandable stent system (Photo courtesy of Covidien).
A balloon-expandable stent system helps patients regain blood flow by treating lesions of the common and external iliac arteries.

The Visi-Pro balloon-expandable stent system is intended to improve and maintain artery luminal diameter in occlusions or lesions at high risk for abrupt closure following percutaneous transluminal angioplasty (PTA), or in lesions believed to be at high risk of stenosis following PTA in the common and external iliac, subbclavian, and renal arteries. The stent is also indicated for use as a palliative treatment of malignant neoplasms in the biliary tree.

The Visi-Pro is made from a 316L stainless steel tube with a diameter of 0.9 mm cut into an open lattice design; tantalum radiopaque markers are placed at the proximal and distal ends of the stent for guided placement. For delivery, the stent is mounted onto a tightly-folded balloon catheter, and then expanded and deployed by inflating the balloon. Other features include solid radial strength, flexibility, superior trackability, and a unique 5-fold balloon wrap that improves retraction.

In a prospective, multicenter, nonrandomized study that enrolled 75 patients at 17 centers in the United States and Europe, The Visi-Pro met its primary nine month endpoint, with a major adverse event rate of just 4%. Additionally, the technology achieved 100% device success, with primary patency and freedom from clinically-driven target lesion revascularization at nine months at 95.8%. The Visi-Pro is a product of Covidien (Dublin, Ireland), and has received the European Community CE marking of approval.

“The nine month results were positive, demonstrating the effectiveness of the technology in treating patients with iliac disease, regardless of gender, lesion location, or severity,” said lead author John Rundback, MD, of the Holy Name Medical Center (Teaneck, NJ, USA). “A unique benefit of the Visi-Pro stent is its excellent visibility during deployment, which optimizes precise positioning and minimizes the risk of geographic miss that is inherent to iliac stent procedures.”

Related Links:

Holy Name Medical

Cincinnati Sub-Zero
Asian Healthcare Show


Critical Care

view channel
Image: The StarStream ultrasonic cleaning device (Photo courtesy of Ultrawave).

Ultrasonic Device Cleans Medical Instruments Better

A new study describes an ultrasonic device that creates tiny bubbles that scrub medical device surfaces, thus reducing the need for additives and heating to achieve effective cleaning. The StarStream... Read more

Women's Health

view channel

Pregnancy Complications Raise Heart Disease Risk

A new study suggests a high correlation between women who experienced complications during pregnancy and those facing death from heart disease later in life. Researchers at the Public Health Institute (PHI; Oakland, CA, USA; Berkeley, CA) conducted a study involving 14,062 women, examining pregnancy events over five... Read more

Patient Care

view channel
Image: The NIFTY cup (Photo courtesy of PATH).

NIFTY Cup Aids Infants Who Cannot Breastfeed

A novel cup has been designed to facilitate feeding and prevent starvation in infants in developing countries who are unable to breastfeed. The Neonatal Intuitive Feeding TechnologY (NIFTY) cup, developed... Read more

Hospital News

view channel

Universal Health Services to Acquire Foundations Recovery Network

Hospital operator Universal Health Services (UHS; King of Prussia, PA, USA) has entered an agreement to buy addiction treatment provider Foundations Recovery Network (FRN; Brentwood, TN, USA) for USD 350 million. Founded in 1995, FRN is a leader in addiction treatment and focused on treating adults with addiction and... Read more


view channel

Qualcomm Buys Connectivity Company Capsule Technologie

Qualcomm Life (San Diego, CA, USA) has purchased Capsule Technologie (Andover, MA, USA) in a bid to become one of the world's largest open connected health ecosystems. Financial details remain undisclosed. Qualcomm Life, a division of the 3G, 4G, and next-generation wireless technology conglomerate Qualcomm (San Diego,... Read more


08 Oct 2015 - 10 Oct 2015
08 Oct 2015 - 10 Oct 2015
08 Oct 2015 - 10 Oct 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.